Active substance
Doxapram
- US FDA 3
- UK MHRA 5
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| DOPRAM | 20MG/ML | injectable · injection | HIKMA PHARMS | Prescription | 23 Jun 1965 |
| DOXAPRAM HYDROCHLORIDE | 20MG/ML | injectable · injection | CHARTWELL INJECTABLE | Prescription | 10 Jan 2003 |
| DOXAPRAM HYDROCHLORIDE | 20MG/ML | injectable · injection | WATSON LABS | Discontinued | 30 Jan 1992 |
UK MHRA United Kingdom — marketing authorisations
| Product | Authorisation | Holder | Legal status |
|---|---|---|---|
| DOPRAM INFUSION | PL 12762/0623 | MERCURY PHARMACEUTICALS LIMITED | POM |
| DOPRAM INJECTION | PL 12762/0573 | MERCURY PHARMACEUTICALS LIMITED | POM |
| DOXAPRAM HYDROCHLORIDE 20 MG/ML SOLUTION FOR INJECTION | PL 39280/0017 | SYNCHRONY PHARMA LIMITED | POM |
| DOXAPRAM HYDROCHLORIDE 20MG/ML SOLUTION FOR INJECTION | PL 12762/0573 | MERCURY PHARMACEUTICALS LIMITED | POM |
| DOXAPRAM HYDROCHLORIDE 2MG/ML SOLUTION FOR INFUSION | PL 12762/0623 | MERCURY PHARMACEUTICALS LIMITED | POM |
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), MHRA category lists of UK marketing authorisations (Open Government Licence v3.0), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.